Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Behrens

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Current Opinion in HIV and AIDS|May 21, 2014
Liver fibrosis in HIV: which role does HIV itself, long-term drug toxicities and metabolic changes play?Jürgen K Rockstroh, Raphael Mohr, Georg Behrens, et al.
Pneumologie (Stuttgart, Germany)|May 28, 2025
[Unmasking immune reconstitution inflammatory syndrome (IRIS) in XDR-TB-HIV coinfection: a case report]Sabrina Welland, Franz Christoph Bange, Georg Behrens, et al.
Antiviral Therapy|August 23, 2012
Switching to tenofovir/emtricitabine from abacavir/lamivudine in HIV-infected adults with raised cholesterol: effect on lipid profilesGeorg Behrens, Renato Maserati, Armin Rieger, et al.
Acta Dermato-Venereologica|November 22, 2016
Increased Activity and Apoptosis of Eosinophils in Blister Fluids, Skin and Peripheral Blood of Patients with Bullous PemphigoidJudith Engmann, Urda Rüdrich, Georg Behrens, et al.
AIDS (London, England)|July 19, 2006
High serum urate in HIV-infected persons: the choice of the antiretroviral drug mattersUlrich A Walker, Christian Hoffmann, Mark Enters, et al.
AIDS Reviews|March 11, 2010
Epidemiology, assessment, and management of excess abdominal fat in persons with HIV infectionGraeme Moyle, Michel Moutschen, Esteban Martínez, et al.
Hepatology (Baltimore, Md.)|October 24, 2006
Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotypeTim O Lankisch, Ulrike Moebius, Michael Wehmeier, et al.
Immunology and Cell Biology|February 27, 2004
Helper T cells, dendritic cells and CTL ImmunityGeorg Behrens, Ming Li, Christopher M Smith, et al.
Retrovirology|May 3, 2013
Platelet activation suppresses HIV-1 infection of T cellsTheodros Solomon Tsegaye, Kerstin Gnirß, Niels Rahe-Meyer, et al.
Plos One|July 9, 2016
Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial TherapyJosep M Llibre, François Raffi, Graeme Moyle, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Current Opinion in HIV and AIDS|May 21, 2014
Liver fibrosis in HIV: which role does HIV itself, long-term drug toxicities and metabolic changes play?Jürgen K Rockstroh, Raphael Mohr, Georg Behrens, et al.
Pneumologie (Stuttgart, Germany)|May 28, 2025
[Unmasking immune reconstitution inflammatory syndrome (IRIS) in XDR-TB-HIV coinfection: a case report]Sabrina Welland, Franz Christoph Bange, Georg Behrens, et al.
Antiviral Therapy|August 23, 2012
Switching to tenofovir/emtricitabine from abacavir/lamivudine in HIV-infected adults with raised cholesterol: effect on lipid profilesGeorg Behrens, Renato Maserati, Armin Rieger, et al.
Acta Dermato-Venereologica|November 22, 2016
Increased Activity and Apoptosis of Eosinophils in Blister Fluids, Skin and Peripheral Blood of Patients with Bullous PemphigoidJudith Engmann, Urda Rüdrich, Georg Behrens, et al.
AIDS (London, England)|July 19, 2006
High serum urate in HIV-infected persons: the choice of the antiretroviral drug mattersUlrich A Walker, Christian Hoffmann, Mark Enters, et al.
AIDS Reviews|March 11, 2010
Epidemiology, assessment, and management of excess abdominal fat in persons with HIV infectionGraeme Moyle, Michel Moutschen, Esteban Martínez, et al.
Hepatology (Baltimore, Md.)|October 24, 2006
Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotypeTim O Lankisch, Ulrike Moebius, Michael Wehmeier, et al.
Immunology and Cell Biology|February 27, 2004
Helper T cells, dendritic cells and CTL ImmunityGeorg Behrens, Ming Li, Christopher M Smith, et al.
Retrovirology|May 3, 2013
Platelet activation suppresses HIV-1 infection of T cellsTheodros Solomon Tsegaye, Kerstin Gnirß, Niels Rahe-Meyer, et al.
Plos One|July 9, 2016
Correction: An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial TherapyJosep M Llibre, François Raffi, Graeme Moyle, et al.
Pageof 4